Physician profile
Riya Mohan
NPI 1487115382
$2,169.35
in general payments reported to CMS, 2019-2025
16 companies · $784 in 2025
The $784 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $64.15 · 2022: $202 · 2023: $283 · 2024: $835 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,807 · Education: $95.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,807.34 |
| Education | $95.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $511.65 | 2020-2025 | Ensite, Mitraclip, Aveir |
| Abiomed | $333.48 | 2024-2025 | Impella |
| Shockwave Medical, INC | $190.58 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $184.49 | 2025 | Micra, Mycarelink |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.07 | 2024 | Jardiance |
| Boston Scientific Corporation | $146.90 | 2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $140.86 | 2022-2025 | Wainua |
| Cardiva Medical, INC. | $113.66 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Astellas Pharma US INC | $90.99 | 2022 | |
| Alnylam Pharmaceuticals INC. | $89.97 | 2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $59.94 | 2024 | |
| Edwards Lifesciences Corporation | $48.21 | 2025 | Edwards Intuity Elite Valve System |
| Biosense Webster, INC. | $32.82 | 2025 | Carto 3 |
| Atricure, INC. | $27.91 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Terumo Medical Corporation | $27.32 | 2024 | Angio-Seal |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riya Mohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.